Tweet
RTT News
<img alt="" height="1" width="1" />
ImmunoGen shares sink after cancer drug setback
BusinessWeek
Shares of ImmunoGen Inc. sank in Friday trading after the company said federal regulators declined to accept an application for accelerated approval for a potential breast cancer treatment. THE SPARK: ImmunoGen, which is based in Waltham, Mass., ...
Roche's Hopes For Speedy Drug Approval DashedWall Street Journal
Roche's Ills And CuresRTT News
Roche Breast Cancer Drug Trastuzumab-DM1 Review Turned Down By FDAMedical News Today
San Francisco Business Times -Mass High Tech -MarketNewsVideo.com
all 144 news articles »
More...